Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients

24Citations
Citations of this article
49Readers
Mendeley users who have this article in their library.

Abstract

MET alterations may provide a potential biomarker to evaluate patients who will benefit from treatment with MET inhibitors. Therefore, the purpose of the present study is to investigate the utility of a liquid biopsy-based strategy to assess MET alterations in cancer patients. We analyzed MET amplification in circulating free DNA (cfDNA) from 174 patients with cancer and 49 healthy controls and demonstrated the accuracy of the analysis to detect its alteration in patients. Importantly, a significant correlation between cfDNA concentration and MET copy number (CN) in cancer patients (r = 0.57, p <10-10) was determined. Furthermore, we evaluated two approaches to detect the presence of MET on circulating tumor cells (CTCs), using the CellSearch® and Parsortix systems and monitored patients under anti-EGFR treatment (n = 30) combining both cfDNA and CTCs analyses. This follow-up provides evidence for the potential of MET CN assessment when patients develop resistance to anti-EGFR therapy and a significant association between the presence of CTCs MET+ and the Overall Survival (OS) in head and neck cancer patients (P = 0.05; HR = 6.66). In conclusion, we develop specific and noninvasive assays to monitor MET status in cfDNA/CTCs and demonstrate the utility of plasma MET CN determination as a biomarker for monitoring the appearance of resistance to anti-EGFR therapy.

Cited by Powered by Scopus

Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg?

47Citations
N/AReaders
Get full text

Current status and future perspectives of liquid biopsy in small cell lung cancer

25Citations
N/AReaders
Get full text

Clinical potential of circulating free DNA and circulating tumour cells in patients with metastatic non-small-cell lung cancer treated with pembrolizumab

22Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Mondelo-Macía, P., Rodríguez-López, C., Valiña, L., Aguín, S., León-Mateos, L., García-González, J., … López-López, R. (2020). Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients. Cells, 9(2). https://doi.org/10.3390/cells9020522

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 13

59%

Researcher 6

27%

Lecturer / Post doc 2

9%

Professor / Associate Prof. 1

5%

Readers' Discipline

Tooltip

Medicine and Dentistry 11

46%

Biochemistry, Genetics and Molecular Bi... 11

46%

Pharmacology, Toxicology and Pharmaceut... 1

4%

Chemistry 1

4%

Save time finding and organizing research with Mendeley

Sign up for free